Treatment of acute granulocytic leukemias

Annu Rev Med. 1974:25:39-51. doi: 10.1146/annurev.me.25.020174.000351.
No abstract available

Publication types

  • Review

MeSH terms

  • Adult
  • Age Factors
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects
  • Blood Cell Count
  • Blood Platelets
  • Bone Marrow Examination
  • Child
  • Cytarabine / administration & dosage
  • Cytarabine / pharmacology
  • Cytarabine / therapeutic use*
  • Daunorubicin / administration & dosage
  • Daunorubicin / adverse effects
  • Daunorubicin / therapeutic use*
  • Doxorubicin / administration & dosage
  • Doxorubicin / therapeutic use*
  • Drug Therapy, Combination
  • Heart / drug effects
  • Hemorrhage / etiology
  • Humans
  • Hydrazones / therapeutic use
  • Injections, Intravenous
  • Leukemia, Monocytic, Acute / drug therapy
  • Leukemia, Myeloid / drug therapy
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukocyte Count

Substances

  • Antineoplastic Agents
  • Hydrazones
  • Cytarabine
  • Doxorubicin
  • Daunorubicin